Is everolimus available in China?

Everolimus is a drug that belongs to a class of immunosuppressants and is also a targeted therapy drug. It inhibits the activity of the mammalian target of rapamycin (mTOR) signaling pathway, thereby affecting cell growth, division and metabolism to achieve therapeutic effects. Everolimus has been approved for marketing in my country, and has been included in the national medical insurance. The price is about 4000~5000 yuan. It takes about 2 boxes of everolimus per month. For specific prices and medical insurance reimbursement policies, please consult the local hospital pharmacy or medical insurance bureau. The cheaper ones abroad are mainly Indian generic drugs, the price is around 700~1,500yuan, and the ingredients of the drugs are basically the same as those in China.